{
    "title": "AstraZeneca's top-selling cancer drug sees early unblinding in key trial",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8209395/AstraZenecas-selling-cancer-drug-sees-early-unblinding-key-trial.html",
    "date": "2020-04-10",
    "keywords": [
        "cancer",
        "lung",
        "year",
        "trial",
        "drug",
        "tagrisso",
        "recommendation",
        "oncology",
        "company",
        "therapy",
        "plc",
        "benefit",
        "treatment",
        "data",
        "monitoring",
        "committee",
        "jos\u00e9",
        "vice",
        "president",
        "rampd",
        "earlystage",
        "cell",
        "maker",
        "meeting",
        "astrazeneca",
        "latestage",
        "study",
        "type",
        "immunotherapy",
        "multibillion",
        "dollar",
        "deal",
        "co",
        "quarter",
        "forecast",
        "slowdown",
        "revenue",
        "growth",
        "hit",
        "coronavirus",
        "reporting",
        "kanishka",
        "singh",
        "bengaluru",
        "editing",
        "daniel"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}